NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

UBS ASSET MANAGEMENT AMERICAS INC's Holding History (CIK: 0000861177)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 265,199 Value ($000) $9,303 Avg Close $36.39 Range $28.19 - $42.00

Q2 2025

Shares 320,804 Value ($000) $5,810 Avg Close $18.24 Range $14.06 - $22.25

Q1 2025

Shares 288,134 Value ($000) $5,898 Avg Close $22.23 Range $17.18 - $26.80

Q4 2024

Shares 253,571 Value ($000) $6,517 Avg Close $21.24 Range $15.51 - $27.29

Q3 2024

Shares 239,283 Value ($000) $3,972 Avg Close $17.30 Range $15.19 - $21.48

Q2 2024

Shares 17,978 Value ($000) $345 Avg Close $20.06 Range $16.62 - $24.79

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	265,199	$9,303	$36.39	$28.19 - $42.00
Q2 2025	320,804	$5,810	$18.24	$14.06 - $22.25
Q1 2025	288,134	$5,898	$22.23	$17.18 - $26.80
Q4 2024	253,571	$6,517	$21.24	$15.51 - $27.29
Q3 2024	239,283	$3,972	$17.30	$15.19 - $21.48
Q2 2024	17,978	$345	$20.06	$16.62 - $24.79